Mattias Wieloch
1 – 28 of 28
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Effect of dronedarone vs. placebo on atrial fibrillation progression : a post hoc analysis from ATHENA trial
2023) In Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 25(3). p.845-854(
- Contribution to journal › Article
-
Mark
Novel methodology for the evaluation of symptoms reported by patients with newly diagnosed atrial fibrillation : Application of natural language processing to electronic medical records data
(
- Contribution to journal › Article
-
Mark
Dronedarone Versus Sotalol in Antiarrhythmic Drug-Naive Veterans With Atrial Fibrillation
(
- Contribution to journal › Article
-
Mark
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
(
- Contribution to journal › Article
- 2022
-
Mark
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction : a post-hoc analysis of the ATHENA trial
(
- Contribution to journal › Article
-
Mark
Effect of Dronedarone in the Treatment of Atrial Fibrillation in the Asian Population : Post Hoc Analysis of the ATHENA Trial
(
- Contribution to journal › Article
-
Mark
Impact of dronedarone on patients with atrial fibrillation and diabetes : A sub-analysis of the ATHENA and EURIDIS/ADONIS studies
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function : Post hoc analyses of the EURIDIS-ADONIS trials
(
- Contribution to journal › Article
- 2021
-
Mark
Evaluating the Risk of Digitalis Intoxication Associated With Concomitant Use of Dronedarone and Digoxin Using Real-World Data
(
- Contribution to journal › Article
-
Mark
Risk of Major Bleeding in Patients With Atrial Fibrillation Taking Dronedarone in Combination With a Direct Acting Oral Anticoagulant (From a U.S. Claims Database)
(
- Contribution to journal › Article
-
Mark
Amino acids predict prognosis in patients with acute dyspnea
(
- Contribution to journal › Article
- 2020
-
Mark
Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter : A post hoc analysis of the EURIDIS and ADONIS trials
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter : Insights from the ATHENA study
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of dronedarone by atrial fibrillation history duration : Insights from the ATHENA study
(
- Contribution to journal › Article
- 2017
-
Mark
Ischemic stroke rates decline in patients with atrial fibrillation as anticoagulants uptake improves : A Swedish cohort study
(
- Contribution to journal › Article
- 2016
-
Mark
Inflammatory biomarkers predicting prognosis in patients with acute dyspnea.
(
- Contribution to journal › Article
- 2015
-
Mark
Skåne Emergency Department Assessment of Patient Load (SEAL)-A Model to Estimate Crowding Based on Workload in Swedish Emergency Departments.
(
- Contribution to journal › Article
-
Mark
Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.
(
- Contribution to journal › Article
- 2014
-
Mark
Bleeding complications related to warfarin treatment: a descriptive register study from the anticoagulation clinic at Helsingborg Hospital
(
- Contribution to journal › Article
-
Mark
Thromboembolism, major bleeding and mortality in patients with mechanical heart valves- a population-based cohort study.
(
- Contribution to journal › Article
- 2013
-
Mark
Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin.
(
- Contribution to journal › Article
-
Mark
Dabigatran in clinical practice - One-year experience at Skåne University Hospital.
(
- Contribution to journal › Letter
- 2012
-
Mark
Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
(
- Contribution to journal › Article
-
Mark
Referring physicians underestimate the extent of abnormalities in final reports from myocardial perfusion imaging
(
- Contribution to journal › Article
- 2011
-
Mark
Oral anticoagulation treatment in atrial fibrillation - To bleed or not to bleed, that is the question
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.
(
- Contribution to journal › Article
-
Mark
Glomerular filtration rate in patients with atrial fibrillation on warfarin treatment: A subgroup analysis from the AURICULA registry in Sweden.
(
- Contribution to journal › Article
- 2009
-
Mark
Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
(
- Contribution to journal › Article